This prospective non-randomised trial of 128 selected patients with unresectable oesophageal or gastrooesophageal junction cancers aims to evaluate the initial relief of malignant obstruction by means of bipolar electrocoagulation for both circumferential and submucosal strictures of Nd:YAG laser for the other patients. A limited dilatation was performed initially if a small calibre endoscope was unable to pass through the stricture. Prompt and significant relief ofdysphagia without complications was achieved in 83% of patients. Improved patients were retreated monthly during the follow up period. Radiotherapy was recommended when possible.
Patients with oesophageal squamous cell carcinomas or gastrooesophageal junction adenocarcinomas have a poor prognosis: five year survival being about 10%.' 2 Surgical resection is the main curative treatment, but is limited to the early stages of disease. For other cases, various palliative treatments are available. The aim of these treatments is to restore and then to maintain a normal or almost normal food intake through the patient's survival. Dilatation, stents, Nd:YAG laser photocoagulation, bipolar electrocoagulation, and radiotherapy are the most commonly used techniques.`This work reports the results of a four year prospective study using dilatation, laser and/or bipolar electrocoagulation, and eventually radiotherapy in 128 (Table  II) . Eight patients had a jejunostomy after surgical exploration which revealed that the cancer was unsuitable for resection. Figure 1 shows the location and the histology, Figure 2 . Table III gives the duration of improvement for the laser group and bipolar electrocoagulation group, with or without radiotherapy. Reasons for discontinuing treatment are given in Table IV. Improvement duration was significantly related to the circumferential extension of the tumour base (Fig 5) . The recommendation for radiotherapy after relief of obstruction with endoscopic therapy was associated with a longer duration of improvement (Fig 6) 
Discussion
The vast majority of patients with obstructing oesophageal or gastrooesophageal junction carcinomas are not curable by the time of presentation and few survive beyond one year.7 Such patients may benefit from palliative therapy, however, which aims to allow an almost normal food intake until death. From this point of view, palliative treatment has to be not only quickly effective but also well tolerated, without prolonged hospital stay and with a low rate of complications. This study aimed to evaluate in a non-randomised prospective trial the initial relief of malignant obstruction by means of laser or bipolar electrocoagulation with a previous dilatation if necessary. We also studied the long term follow up palliation with repeated endoscopic treatments using the same endoscopic procedures and radiotherapy if recommended.
Like Jensen,' we do not think that all referred patients necessarily benefit from endoscopic Nd:YAG or bipolar electrocoagulation tumour probe treatment. We excluded 69 patients (35%): 14 were referred for a more appropriate treatment because they did not have a true dysphagia or could be operated on. Patients were referred to us for palliation and this is the origin of the small number of candidates for surgery or radiotherapy. Twenty two patients were not treated because of their poor general condition. Mellow6 showed that poor performance status (including severe anorexia) at accession is correlated with poor functional outcome. Twenty seven cancers were deemed unsuitable for endoscopic procedures because of (a) a non-dilatable stenosis which did not permit a safe thermal treatment9 and so were treated with jejunostomy, (b) a fistula or extrinsic compression and so were treated with endoprosthesis. The last six patients were excluded for miscellaneous causes as already described.
Routine upper gastrointestinal endoscopies are performed in our hospital without sedation. With our parameters, laser application is not painful by itself. Thus, laser treatments were carried out without sedation. Sedation was used for bipolar electrocoagulation treatments because the procedure was more uncomfortable, requiring the successive placements of a guidewire, a rigid bipolar electrocoagulation probe with a semi rigid handle, and a small endoscope.
Prompt reliefofobstruction without complications and prolonged hospitalisation was achieved in most patients (83%). Fifty 'six (43%) had dilatation during initial treatment. It is assumed that through the scope balloon dilatation is effective for treating complex malignant strictures.'0 Its main advantages are dilatation under endoscopic guidance with the forces applied radially. After balloon dilatation, a small calibre endoscope can be passed through the stricture, and this facilitates guide wire placement for subsequent Savary dilatation needed to reinforce the balloon dilatation. Using this careful and limited in diameter method of dilatation (11 to 12-8 mm), no complications occurred in our series at this initial stage of the treatment. Such dilatation of tight malignant strictures did not aim to really improve dysphagia but was only considered as the first step of the endoscopic treatment," " before thermal treatment.
Laser treatment of malignant oesophageal obstruction is an effective method for palliation of dysphagia. It is usually well tolerated and can be performed in outpatients.9 Our retrograde method using non-contact fibres and low irradiance is as effective as vaporisation with high irradiance.4`Indeed, our improvement rate (81%) is equal or higher than the rates of 69% to 86% reported in eight series with a minimum of 30 patients treated with high irradiance. " Usual parameters found in the literature which influence the initial success rate adversely are (a) a tumour length >5 cm,' (b) a complex stricture at the gastrooesophageal junction,' (c) a submucosal tumour' and (d) an upper third location.'6`In our opinion, a contrast swallow and endoscopic examination give a poor indication of the length of tumour or stricture. Thus, we did not look at this parameter even if we agree that long stenoses are more difficult to treat. In our laser group, the factor indicating bad prognosis was laser treatment for a recurrence, contrary to Rutgeerts experience. ' The length of time that symptomatic relief persists is difficult to evaluate because few studies report standardised follow up data. In Rutgeerts's series,' duration of laser palliation averaged 11 weeks and palliation until death was obtained in 62% of patients. In Naveau's study,'6 the cumulative probabilities of remaining improved at three and six months in patients initially treated with success were 38 5% and 22%. In our series, the average duration of improvement was 17 weeks and the same probabilities were 60% and 29%. The importance of initial improvement and an adenocarcinoma were positively correlated with the duration of improvement in Naveau's series and the initial tumour length was negatively correlated. The longer duration of improvement in our series may be the result of monthly retreatment with various procedures and to radiotherapy when it was possible. In our series, the initial extension of annular size of the tumour base and adjuvant radiotherapy were the two factors influencing improvement of duration. The positive influence of adjuvant radiotherapy was also found in a recent pilot study which suggested a trend towards longer survival in patients treated with laser followed by radiation compared with laser alone23 although neither series gave a randomised comparison, and the patients treated by radiotherapy had less advanced disease than those who were not.
Laser treatment provides good palliation in the majority of patients with unresectable oesophageal or gastrooesophageal junction cancers. The bipolar electrocoagulation tumour probe offers a palliative solution for the minority of patients with submucosal, circumferential and tight malignant stricture. These procedures were well tolerated and associated with low morbidity while following our method in selected patients. The long term maintenance of improvement is positively influence by a monthly repeated treatment using the best procedure for the tumour configuration. Radiotherapy may be of value for some patients to slow down tumour regrowths after endoscopic relief for obstruction.
